Levadopa and anticholinergic drugs in Parkinsonism.
D001479:Basal Ganglia / Q000032:analysis; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004298:Dopamine / Q000032:analysis; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D013378:Substantia Nigra / Q000032:analysis
D010276:Parasympatholytics; D004295:Dihydroxyphenylalanine; D004298:Dopamine